Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Loan Conversion

23 Dec 2005 07:00

Embargoed Release: 07:00hrs Friday 23rd December 2005 SOPHEON PLC Conversion of loan stock Extension of Equity Line Agreement International Financial Reporting Standards Change of Auditors Sopheon plc announces that it has issued 10,197,327 ordinary shares inconnection with the maturity of its remaining balance of ‚£1,223,679 ofconvertible loan stock. The convertible loan stock is now fully converted, asforeseen in Sopheon's annual report and other announcements. The conversion hasresulted in the issue of 3,250,000 ordinary shares to Mr B K Mence, a director,changing the total holding in which Mr Mence is beneficially interested to14,423,847 ordinary shares, representing 10.8% of the Company's issued sharecapital. The conversion has also resulted in the issue of 5,416,667 ordinaryshares to Norman Nominees Limited, changing its total shareholding to 9,891,260ordinary shares, representing 7.4% of the Company's issued share capital.Application has been made for the new ordinary shares, which are subject tocertain lock-in requirements, to be admitted to trading on AIM. Dealings areexpected to commence on 3 January 2006.Sopheon is also pleased to advise that its equity line of credit facility withGEM Global Yield Fund Limited ("GEM") due to expire today has been extended fora two year period through to 23 December 2007. As part of the agreement, thecosts of the extension, as well as outstanding commitment fees relating to theinitial term, have been satisfied by the issue of 400,000 ordinary shares toGEM at a price of 18p per ordinary share. Over 90% of the original ¢â€š¬10mfacility remains available under the extended agreeement. Application has beenmade for the new ordinary shares to be admitted to trading on AIM, and dealingsare expected to commence on 3 January 2006.Although Sopheon's AIM listing provides for an exemption from the adoption ofInternational Financial Reporting Standards ("IFRS") until the financialstatements for the year 2007, the board has continued to evaluate the relativemerits of early adoption of IFRS as opposed to continued application of UKGAAP. In view of the increasing importance of the group's shareholders thattrade through Euronext, coupled with the effect of extensive changes comingthrough in UK GAAP relating to its convergence with IFRS, the board has nowconcluded in consultation with its advisers that adoption of IFRS as of the2005 financial statements is appropriate.A detailed evaluation of the effects of the adoption of IFRS on Sopheon'sfinancial statements is ongoing but the preliminary conclusions as to the keyareas likely to be materially affected are (i) an option pricing model will beused to work out the fair value of share options granted during a period, withthis value being charged to the profit and loss account over the expectedvesting period; (ii) certain research and development expenditure may becapitalised and amortised based on detailed technical criteria, rather thanautomatically charging such costs in the profit and loss account as they arise;(iii) certain short term non-trade payables and receivables may requirerestatement or reclassification and (iv) certain acquired goodwill may requirereclassification as an intangible asset. It is not expected that the treatmentand reporting of Sopheon's revenues will be affected by the adoption of IFRS.Finally, the Sopheon board wishes to announce that BDO Stoy Hayward hasreplaced Ernst & Young as auditors with immediate effect. BDO is the world'sfifth largest accountancy network. Its focus on growth oriented companiesaligns well with Sopheon's business characteristics, and will deliver a morecost effective audit service. The BDO member firms in the Netherlands and inthe USA are respectively BDO CampsObers Accountants & Belastingadviseurs, andBDO Seidman LLP. Ernst & Young remain Sopheon's tax advisers.For further information contact:Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100 Andrew Tan + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 ENDSOPHEON PLC
Date   Source Headline
6th Dec 20137:00 amRNSDirector/PDMR Shareholding
5th Dec 20137:00 amRNSCorporate Update
19th Nov 20137:00 amRNSSopheon Delivers Accolade® Release 9.0
7th Nov 20137:00 amRNSInterim Management Statement
11th Sep 20133:00 pmRNSHolding(s) in Company
4th Sep 20133:00 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSInterim Results
15th Aug 20133:00 pmRNSHolding(s) in Company
29th Jul 20133:00 pmRNSHolding(s) in Company
26th Jul 20137:00 amRNSTrading Update
15th Jul 20134:15 pmRNSHolding(s) in Company
28th Jun 20133:00 pmRNSTotal Voting Rights
27th Jun 20133:00 pmRNSHolding(s) in Company
19th Jun 20133:42 pmRNSHolding(s) in Company
19th Jun 20137:00 amRNSNew capabilities with Accolade(R) 8.3
14th Jun 20132:00 pmRNSContract Win
12th Jun 201312:00 pmRNSResult of AGM & GM
12th Jun 20137:00 amRNSAGM Statement
4th Jun 20137:00 amRNSIssue of Shares
2nd May 20137:00 amRNSInterim Management Statement
21st Mar 20137:00 amRNSPreliminary Results
30th Jan 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSLaunch of Accolade 8.2
7th Dec 201211:36 amPRNHolding(s) in Company
8th Nov 20127:00 amPRNInterim Management Statement
1st Oct 20127:00 amRNSHolding(s) in Company
1st Oct 20127:00 amRNSDirectors' Options
24th Sep 20127:00 amRNSMarket Transfer to NYSE Alternext Concluded
23rd Aug 20127:00 amRNSAmendment to Terms of Convertible Loan Stock
23rd Aug 20127:00 amRNSInterim Results
23rd Jul 20127:00 amRNSTrading Update
13th Jun 20123:14 pmRNSResult of AGM
13th Jun 20127:00 amRNSAGM Statement
15th May 20127:00 amRNSAmendment to terms of Convertible Loan Stock
3rd May 20127:00 amRNSInterim Management Statement
25th Apr 20127:00 amRNSLaunch of Accolade 8.0
22nd Mar 20127:00 amRNSPreliminary Results
16th Feb 20127:00 amRNSTop 10 Solution Provider to CGM
31st Jan 20127:00 amRNSTrading Update
23rd Dec 201112:32 pmRNSExtension of GEM Equity Line
23rd Dec 201112:29 pmRNSTrading Update
5th Dec 201112:40 pmRNSHolding(s) in Company
3rd Nov 20117:00 amRNSInterim Management Statement
25th Aug 20117:00 amRNSInterim Results
25th Jul 20117:00 amRNSTrading Statement
23rd Jun 20112:15 pmRNSDirector/PDMR Shareholding
15th Jun 20117:00 amRNSAGM Statement
5th May 20117:00 amRNSInterim Management Statement
24th Mar 20117:00 amRNSPreliminary Results
10th Feb 20117:00 amPRNAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.